§ Federal grant opportunity · HT942526LCRPTRA

    DoW Lung Cancer Translational Research Award

    Danielle Reckley Grantor is accepting applications for DoW Lung Cancer Translational Research Award. The deadline is September 2, 2026 and the published award range is Award amount not published.

    Key facts

    Funder
    Danielle Reckley Grantor
    Application deadline
    September 2, 2026
    Award range
    Award amount not published
    Eligibility
    Eligibility criteria are published in the funding opportunity announcement.
    Geography
    United States
    Focus areas
    Research
    Opportunity number
    HT942526LCRPTRA

    Program overview

    Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis. Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.

    How to apply

    1. Confirm your organization meets the eligibility criteria above.
    2. Read the full funding opportunity announcement from Danielle Reckley Grantor.
    3. Draft your narrative against the funder's stated priorities and review criteria.
    4. Submit before September 2, 2026, allowing time for registration and validation.

    View the official funding announcement

    Find every grant your organization qualifies for

    Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.